CrossrefInfokarte
Efficacy and adverse reaction risk factors of immunotherapy in advanced non-small cell lung cancer: a retrospective study
American Journal of Cancer Research · 2026 · 16 (10) · 4637-4648
DOI: 10.62347/dfep8664 ↗Abstract
Kein Abstract verfügbar.
EUVIMED